About PharmatrophiX

San Francisco's PharmatrophiX, a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.

Company Highlights
Year Founded

2005

icon-altEmployees

1

Location (HQ)

USA

Since Last Funding

8 years 9 months

Monthly Website Visitors

751

icon-altTotal Investment Amt

$12M

Last Funding Round

Debt Financing

icon-altYoY Headcount Growth

-47.62%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Pharmaceutical